Detalhe da pesquisa
1.
Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
Cancer
; 119(24): 4268-76, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114811